Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-22

Clinical Trial Update: Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population [Phase 3]

View source ↗

Summary

A Phase 3 study in children comparing insulin aspart, insulin lispro, and regular insulin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • Regular insulin (insulin)
  • insulin lispro (insulin lispro)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED